Portola Investor Wants Docs About $1.4B Alexion Deal
A Portola Pharmaceuticals investor filed a lawsuit Tuesday in Delaware Chancery Court seeking records from the biotech company to probe possible wrongdoing related to its proposed $1.4 billion purchase by Alexion...To view the full article, register now.
Already a subscriber? Click here to view full article